The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs

Completed · Phase 4

Conditions studied: HIV Infections

In brief

To evaluate the safety and antiretroviral activity of saquinavir soft gelatin capsule formulation (SQV-SGC) in combination with other antiretroviral drugs.

Key facts

Study ID

NCT00002425

Run by

Hoffmann-La Roche

People needed

400

Last updated by the study team

2005-06-24

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Concurrent Medication:
• Allowed:
• Antiretroviral treatments other than PIs.
• Patients must have:
• HIV infection.
• No prior experience with PIs. (Note:
• At least 75 percent of patients must be naive to PIs.)

You may not qualify if…

• Concurrent Medication:
• Excluded:
• PIs other than SQV.
• Prior Medication:
• Excluded:
• Any PIs (see note in General Criteria--Inclusion).

Where it is running

• Consumer Contact — Nutley, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.